KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Treasury Shares: 2020-2025

Historic Treasury Shares for Supernus Pharmaceuticals (SUPN) over the last 5 years, with Sep 2025 value amounting to $397,543.

  • Supernus Pharmaceuticals' Treasury Shares fell 1.43% to $397,543 in Q3 2025 from the same period last year, while for Sep 2025 it was $397,543, marking a year-over-year decrease of 1.43%. This contributed to the annual value of $378,165 for FY2024, which is 26.00% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Treasury Shares stood at $397,543, which was down 9.49% from $439,216 recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Treasury Shares ranged from a high of $439,216 in Q2 2025 and a low of $89,125 during Q3 2021.
  • Its 3-year average for Treasury Shares is $373,140, with a median of $396,908 in 2024.
  • In the last 5 years, Supernus Pharmaceuticals' Treasury Shares skyrocketed by 242.06% in 2021 and then fell by 1.43% in 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Treasury Shares (Quarterly) stood at $89,125 in 2021, then skyrocketed by 126.37% to $201,750 in 2022, then surged by 48.77% to $300,141 in 2023, then grew by 26.00% to $378,165 in 2024, then fell by 1.43% to $397,543 in 2025.
  • Its Treasury Shares was $397,543 in Q3 2025, compared to $439,216 in Q2 2025 and $407,867 in Q1 2025.